Drug intelligence / Profile preview

vesicular stomatitis virus

Development stage
Phase 2
Lead developer
University of Oxford
Modality
Viral Vectors → Gene Addition/Replacement → Gene Therapies, Oncolytic Viruses → Oncolytic Therapeutics, Vaccines & Immunotherapeutics
Administration
Intravenous, Intratumoral
01

Overview

Vesicular stomatitis virus is an enveloped, non-segmented, negative-strand RNA virus and the prototypic member of the genus Vesiculovirus in the family Rhabdoviridae[1][3][5]. VSV is an arbovirus, primarily infecting livestock (cattle, horses, swine), where it causes oral and dermal vesicular lesions, and it can occasionally infect humans causing mild, flu-like symptoms[3][7]. Major structural proteins include the glycoprotein (G), nucleoprotein (N), phosphoprotein (P), matrix protein (M), and large polymerase protein (L)[1][3][5]. VSV is widely used in research and medicine as a laboratory tool, viral vector, vaccine platform, and oncolytic virus[2][4][6]. Its unique ability to selectively replicate in cells with defective interferon signaling, commonly found in tumors, underlies its application as an oncolytic virus and vector for immunovirotherapy[6]. VSV's G protein (VSV-G) has extensive use in pseudotyping other viral vectors and enabling efficient gene, protein, and mRNA delivery[4][8]. VSV's genome can accommodate foreign genes and is amenable to genetic manipulation, further expanding its utility for gene and cancer immunotherapy, vaccines, and advanced therapy medicinal products[2][4][6]. Two main serotypes are known: VSV-Indiana (VSIV or VSV-IND) and VSV-New Jersey (VSV-NJ), with further subtypes within VSV-IND[5].

Other names
vesicular stomatitis Indiana virusVSV-GIndiana vesiculovirusVSV-NJVSV-INDCocal virusAlagoas virus
02

Targets

VSV-N (Vesicular stomatitis virus nucleoprotein)Rae1–Nup98 (Ribonucleic acid export 1–Nucleoporin 98 complex)

Beyond the preview

Go deeper on vesicular stomatitis virus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vesicular stomatitis virus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call